Differential optineurin expression controls TGFβ signaling and is a key determinant for metastasis of triple negative breast cancer
Open Access
- 8 March 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 152 (12) , 2594-2606
Abstract
Triple‐negative breast cancer (TNBC) is the most challenging breast cancer subtype to treat due to its aggressive characteristics and low response to the existing clinical therapies. Distant metastasis is the main cause of death of TNBC patients. Better understanding of the mechanisms underlying TNBC metastasis may lead to new strategies of early diagnosis and more efficient treatment. In our study, we uncovered that the autophagy receptor optineurin (OPTN) plays an unexpected role in TNBC metastasis. Data mining of publicly available data bases revealed that the mRNA level of OPTN in TNBC patients positively correlates with relapse free and distance metastasis free survival. Importantly, in vitro and in vivo models demonstrated that OPTN suppresses TNBC metastasis. Mechanistically, OPTN inhibited the pro‐oncogenic transforming growth factor‐β (TGFβ) signaling in TNBC cells by interacting with TGFβ type I receptor (TβRI) and promoting its ubiquitination for degradation. Consistent with our experimental findings, the clinical TNBC samples displayed a negative correlation between OPTN mRNA expression and TGFβ gene response signature and expression of proto‐typic TGFβ target genes. Altogether, our study demonstrates that OPTN is a negative regulator for TGFβ receptor/SMAD signaling and suppresses metastasis in TNBC.Keywords
Funding Information
- ZonMw (09120012010061)
This publication has 21 references indexed in Scilit:
- The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and TreatmentJournal of Clinical Medicine, 2013
- Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft modelBreast Cancer Research, 2013
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancerJournal of Clinical Investigation, 2013
- USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptorNature Cell Biology, 2012
- Regulating the stability of TGFβ receptors and SmadsCell Research, 2008
- TGFβ induces SIK to negatively regulate type I receptor kinase signalingJournal of Cell Biology, 2008
- Transforming Growth Factor-Beta in Osteolytic Breast Cancer Bone MetastasesClinical Orthopaedics and Related Research, 2003
- Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in OptineurinScience, 2002
- Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor DegradationJournal of Biological Chemistry, 2001
- TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases developmentJournal of Clinical Investigation, 1999